{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35237320", "DateRevised": {"Year": "2022", "Month": "05", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "21"}], "Language": ["eng"], "ELocationID": ["3149293", "10.1155/2022/3149293"], "Journal": {"ISSN": "1687-8450", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "Journal of oncology", "ISOAbbreviation": "J Oncol"}, "ArticleTitle": "Effect of PUVA and NB-UVB Therapy on the Skin Cytokine Profile in Patients with Mycosis Fungoides.", "Pagination": {"StartPage": "3149293", "MedlinePgn": "3149293"}, "Abstract": {"AbstractText": ["Mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma. The aim of the present study was to produce up-to-date information on different phototherapy approaches on skin cytokines in patients with MF.", "A total of 27 patients with mycosis fungoides were treated with phototherapy: NB-UVB (narrow-band ultraviolet B therapy) (10 patients) and PUVA (long-wavelength ultraviolet radiation of spectrum A with the use of skin-photosensitizing furocoumarins) therapy (17 patients). Evaluation of the effectiveness of treatment was carried out using BSA (body surface area) and the modified assessment of the severity of the skin lesions scale (mSWAT) used to quantify tumor mass in cutaneous T-cell lymphomas. Average numbers of procedures were 30.2 and 27.8 in the NB-UVB and PUVA groups, respectively. The median total dose of NB-UVB irradiation was 19.9\u2009J/cm<sup>2</sup> and PUVA therapy was 104.0\u2009J/cm<sup>2</sup>. The overall response to therapy including complete and partial remission was 74.9% in the total group; 70% in the NB-UVB group, and 77.7% in the PUVA therapy group. In the obtained biopsies from lesions, surrounding tissue before treatment and skin samples of four healthy volunteers, the concentration of the IL-1<i>\u03b2</i>, IL-4, IL-6, IL-10, IL-17A, IL-17F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33, IFN-<i>\u03b3</i>, sCD40L, and TNF-<i>\u03b1</i> cytokines was studied. An increase in IL-4 and TNF-<i>\u03b1</i> levels was shown in the lesional skin of patients compared to the skin of healthy controls. After the treatment, positive correlations of mSWAT with the levels of IL22, IL33, and TNF-<i>\u03b1</i> in the tumor tissue were found. The levels of IL10 and IFN-<i>\u03b3</i> after PUVA treatment were increased in comparison to baseline. There was no difference in cytokine levels before/after NB-UVB therapy."], "CopyrightInformation": "Copyright \u00a9 2022 Arfenya E. Karamova et al."}, "AuthorList": [{"Identifier": ["0000-0003-3805-8489"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, Bldg 6, 107076 Moscow, Russia."}, {"Identifier": [], "Affiliation": "RSDC (Russian Society of Dermatovenereologists and Cosmetologists), Moscow, Russia."}], "LastName": "Karamova", "ForeName": "Arfenya E", "Initials": "AE"}, {"Identifier": ["0000-0002-1104-7694"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, Bldg 6, 107076 Moscow, Russia."}], "LastName": "Verbenko", "ForeName": "Dmitry A", "Initials": "DA"}, {"Identifier": ["0000-0002-3129-0050"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, Bldg 6, 107076 Moscow, Russia."}], "LastName": "Vorontsova", "ForeName": "Anastasiia A", "Initials": "AA"}, {"Identifier": ["0000-0003-2545-2129"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, Bldg 6, 107076 Moscow, Russia."}, {"Identifier": [], "Affiliation": "RSDC (Russian Society of Dermatovenereologists and Cosmetologists), Moscow, Russia."}], "LastName": "Zhilova", "ForeName": "Maryana B", "Initials": "MB"}, {"Identifier": ["0000-0001-7214-8176"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, Bldg 6, 107076 Moscow, Russia."}], "LastName": "Nikonorov", "ForeName": "Alexandr A", "Initials": "AA"}, {"Identifier": ["0000-0002-6360-2194"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "All-Russian Research Institute of Medicinal and Aromatic Plants (VILAR), Grina St., 7, 117216 Moscow, Russia."}], "LastName": "Gatiatulina", "ForeName": "Eugenia R", "Initials": "ER"}, {"Identifier": ["0000-0002-2553-0484"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, Bldg 6, 107076 Moscow, Russia."}], "LastName": "Znamenskaya", "ForeName": "Ludmila F", "Initials": "LF"}, {"Identifier": ["0000-0002-7625-0503"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Research Center of Dermatovenereology and Cosmetology, Korolenko St., 3, Bldg 6, 107076 Moscow, Russia."}, {"Identifier": [], "Affiliation": "RSDC (Russian Society of Dermatovenereologists and Cosmetologists), Moscow, Russia."}], "LastName": "Kubanov", "ForeName": "Alexey A", "Initials": "AA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Egypt", "MedlineTA": "J Oncol", "NlmUniqueID": "101496537", "ISSNLinking": "1687-8450"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Willemze R., Cerroni L., Kempf W., et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood . 2019;133(16):1703\u20131714. doi: 10.1182/blood-2018-11-881268.", "ArticleIdList": ["10.1182/blood-2018-11-881268", "PMC6473500", "30635287"]}, {"Citation": "Willemze R., Jaffe E. S., Burg G. WHO-EORTC classification for cutaneous lymphomas. Blood . 2005;105(10):3768\u20133785. doi: 10.1182/blood-2004-09-3502.", "ArticleIdList": ["10.1182/blood-2004-09-3502", "15692063"]}, {"Citation": "Guenova E., Watanabe R., Teague J. E., et al. Th2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clinical Cancer Research . 2013;19(14):3755\u20133763. doi: 10.1158/1078-0432.ccr-12-3488.", "ArticleIdList": ["10.1158/1078-0432.ccr-12-3488", "PMC3715586", "23785046"]}, {"Citation": "Wolk K., Mitsui H., Witte K., et al. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function. Clinical Cancer Research . 2014;20(21):5507\u20135516. doi: 10.1158/1078-0432.ccr-14-0707.", "ArticleIdList": ["10.1158/1078-0432.ccr-14-0707", "25212608"]}, {"Citation": "Yoo J., Shah F., Velangi S., Stewart G., Scarisbrick J. S. Secukinumab for treatment of psoriasis: does secukinumab precipitate or promote the presentation of cutaneous T\u2010cell lymphoma? Clinical and Experimental Dermatology . 2019;44(4):414\u2013417. doi: 10.1111/ced.13777.", "ArticleIdList": ["10.1111/ced.13777", "30284290"]}, {"Citation": "Krejsgaard T., Ralfkiaer U., Clasen-Linde E., et al. Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway. Journal of Investigative Dermatology . 2011;131(6):1331\u20131338. doi: 10.1038/jid.2011.27.", "ArticleIdList": ["10.1038/jid.2011.27", "21346774"]}, {"Citation": "Krejsgaard T., Litvinov I. V., Wang Y., et al. Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma. Blood . 2013;122(6):943\u2013950. doi: 10.1182/blood-2013-01-480889.", "ArticleIdList": ["10.1182/blood-2013-01-480889", "PMC3790948", "23801634"]}, {"Citation": "Miyagaki T., Sugaya M., Suga H., et al. IL-22, but Not IL-17, dominant environment in cutaneous T-cell lymphoma. Clinical Cancer Research . 2011;17(24):7529\u20137538. doi: 10.1158/1078-0432.ccr-11-1192.", "ArticleIdList": ["10.1158/1078-0432.ccr-11-1192", "22048239"]}, {"Citation": "Kienzl P., Polacek R., Reithofer M., et al. The cytokine environment influence on human skin\u2010derived T cells. The FASEB Journal . 2019;33(5):6514\u20136525. doi: 10.1096/fj.201801416r.", "ArticleIdList": ["10.1096/fj.201801416r", "PMC6463918", "30807238"]}, {"Citation": "Karamova A. E., Zhilova M. B., Znamenskaya L. F., Vorontsova A. A. Efficiency of phototherapy in patients with mycosis fungoides: preliminary results of a comparative non-randomized study. Vestnik Dermatologii I Venerologii . 2020;96(5):24\u201330. doi: 10.25208/vdv1188-2020-96-5-24-30.", "ArticleIdList": ["10.25208/vdv1188-2020-96-5-24-30"]}, {"Citation": "Grandi V., Fava P., Rupoli S., et al. Standardization of regimens in narrowband UVB and PUVA in early stage mycosis fungoides: position paper from the Italian task force for cutaneous lymphomas. Journal of the European Academy of Dermatology and Venereology . 2018;32(5):683\u2013691. doi: 10.1111/jdv.14668.", "ArticleIdList": ["10.1111/jdv.14668", "29105200"]}, {"Citation": "Krenitsky A., Ghamrawi R. I., Feldman S. R. Phototherapy: a review and update of treatment options in dermatology. Current Dermatology Reports . 2020;9(1):10\u201321. doi: 10.1007/s13671-020-00290-6.", "ArticleIdList": ["10.1007/s13671-020-00290-6"]}, {"Citation": "Olsen E. A., Whittaker S., Kim Y. H., et al. Clinical end points and response criteria in mycosis fungoides and s\u00e9zary syndrome: a consensus statement of the international society for cutaneous lymphomas, the United States cutaneous lymphoma Consortium, and the cutaneous lymphoma task force of the European organisation for research and treatment of cancer. Journal of Clinical Oncology . 2011;29(18):2598\u20132607. doi: 10.1200/jco.2010.32.0630.", "ArticleIdList": ["10.1200/jco.2010.32.0630", "PMC3422534", "21576639"]}, {"Citation": "Kubanov A. A., Solomka V. S., Karamova A. E., Verbenko D. A., Vasileva E. L., Artamonova O. G. The effect of apremilast therapy on skin cytokine levels in patients with psoriasis. Russian Open Medical Journal . 2020;9(3):p. e0310. doi: 10.15275/rusomj.2020.0310.", "ArticleIdList": ["10.15275/rusomj.2020.0310"]}, {"Citation": "Weinstock M. A., Gardstein B. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. American Journal of Public Health . 1999;89(8):1240\u20131244. doi: 10.2105/ajph.89.8.1240.", "ArticleIdList": ["10.2105/ajph.89.8.1240", "PMC1508695", "10432915"]}, {"Citation": "Ohmatsu H., Humme D., Gulati N., et al. IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization. Cancer Immunology Research . 2014;2(9):890\u2013900. doi: 10.1158/2326-6066.cir-13-0199-t.", "ArticleIdList": ["10.1158/2326-6066.cir-13-0199-t", "PMC4346156", "24938282"]}, {"Citation": "Papadavid E., Economidou J., Psarra A., et al. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sezary syndrome. British Journal of Dermatology . 2003;148(4):709\u2013718. doi: 10.1046/j.1365-2133.2003.05224.x.", "ArticleIdList": ["10.1046/j.1365-2133.2003.05224.x", "12752128"]}, {"Citation": "Beyer M., M\u00f6bs M., Humme D., Sterry W. Pathogenesis of mycosis fungoides. JDDG: Journal der Deutschen Dermatologischen Gesellschaft . 2011;9(8):594\u2013598. doi: 10.1111/j.1610-0387.2011.07635.x.", "ArticleIdList": ["10.1111/j.1610-0387.2011.07635.x", "21371258"]}, {"Citation": "Tsimberidou A.-M., Giles F. J., Duvic M., Kurzrock R. Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas. Journal of the American Academy of Dermatology . 2004;51(2):200\u2013204. doi: 10.1016/j.jaad.2003.05.009.", "ArticleIdList": ["10.1016/j.jaad.2003.05.009", "15280837"]}, {"Citation": "Daliani D., Ulmer R.-A., Jackow C., et al. Tumor necrosis factor-\u03b1 and interferon-\u03b3, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferon-inducible protein-10. Leukemia and Lymphoma . 1998;29(3-4):315\u2013328. doi: 10.3109/10428199809068568.", "ArticleIdList": ["10.3109/10428199809068568", "9684929"]}, {"Citation": "Giri D. K., Aggarwal B. B. Constitutive activation of NF-\u03baB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Journal of Biological Chemistry . 1998;273(22):14008\u201314014. doi: 10.1074/jbc.273.22.14008.", "ArticleIdList": ["10.1074/jbc.273.22.14008", "9593751"]}, {"Citation": "Amitay-Laish I., Guenova E., Ortiz-Romero P., et al. The course of mycosis fungoides under cytokine pathway blockers: a multicentre analysis of real-life clinical data. Acta Dermato-Venereologica . 2020;100(16) doi: 10.2340/00015555-3642.adv00277", "ArticleIdList": ["10.2340/00015555-3642", "32965506"]}, {"Citation": "Wu J., Wood G. S. Analysis of the effect of gentian violet on apoptosis and proliferation in cutaneous T-cell lymphoma in an in vitro study. JAMA dermatology . 2018;154(10):1191\u20131198. doi: 10.1001/jamadermatol.2018.2756.", "ArticleIdList": ["10.1001/jamadermatol.2018.2756", "PMC6233750", "30167641"]}, {"Citation": "Papathemeli D., Patsatsi A., Papanastassiou D., et al. Protein and mRNA expression levels of interleukin-17A, -17F and -22 in blood and skin samples of patients with mycosis fungoides. Acta Dermato-Venereologica . 2020;100(18) doi: 10.2340/00015555-3688.adv00326", "ArticleIdList": ["10.2340/00015555-3688", "33170303"]}, {"Citation": "Grewe M., Gyufko K., Sch\u00f6pf E., Krutmann J. Lesional expression of interferon-\u03b3 in atopic eczema. The Lancet . 1994;343(8888):25\u201326. doi: 10.1016/s0140-6736(94)90879-6.", "ArticleIdList": ["10.1016/s0140-6736(94)90879-6", "7905045"]}, {"Citation": "R\u00e1cz E., Prens E. P., Kurek D., Kant M. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways. Journal of Investigative Dermatology . 201;131(7):1547\u20131558.", "ArticleIdList": ["21412260"]}, {"Citation": "Cope A., Le Friec G., Cardone J., Kemper C. The Th1 life cycle: molecular control of IFN-\u03b3 to IL-10 switching. Trends in Immunology . 2011;32(6):278\u2013286. doi: 10.1016/j.it.2011.03.010.", "ArticleIdList": ["10.1016/j.it.2011.03.010", "21531623"]}, {"Citation": "Krutmann J., H\u00f6nigsmann H. In: Dermatological Phototherapy and Photodiagnostic Methods . Elmets C. A., Bergstresser P. R., editors. Berlin, Germany: Springer; 2009."}, {"Citation": "Sugaya M., Tokura Y., Hamada T., et al. Phase II study of i.v. interferon-gamma in Japanese patients with mycosis fungoides. The Journal of Dermatology . 2014;41(1):50\u201356. doi: 10.1111/1346-8138.12341.", "ArticleIdList": ["10.1111/1346-8138.12341", "24354781"]}, {"Citation": "Del Guzzo C. A., Jariwala N. N., Haun P. L., MacArthur K. M. Pilot study of a novel therapeutic approach for refractory advanced stage folliculotropic mycosis fungoides. Acta Dermato-Venereologica . 2020;100(6):1\u20135. doi: 10.2340/00015555-3443.", "ArticleIdList": ["10.2340/00015555-3443", "32128597"]}, {"Citation": "Enk C. D., Sredni D., Blauvelt A., Katz S. I. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. The Journal of Immunology . 1995;154(9):4851\u20134856.", "ArticleIdList": ["7722334"]}, {"Citation": "Vieyra-Garcia P. A., Wolf P. A deep dive into UV-based phototherapy: mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacology & Therapeutics . 2021;222 doi: 10.1016/j.pharmthera.2020.107784.107784", "ArticleIdList": ["10.1016/j.pharmthera.2020.107784", "33316286"]}, {"Citation": "Vieyra-Garcia P. A., Wolf P. From early immunomodulatory triggers to immunosuppressive outcome: therapeutic implications of the complex interplay between the wavebands of sunlight and the skin. Frontiers of Medicine . 2018;5:p. 232. doi: 10.3389/fmed.2018.00232.", "ArticleIdList": ["10.3389/fmed.2018.00232", "PMC6139367", "30250844"]}, {"Citation": "Phan K., Ramachandran V., Fassihi H., Sebaratnam D. F. Comparison of nar- rowband UV-B with psoralen-UV-A phototherapy for patients with early- stage mycosis fungoides. A systematic review and meta-analysis. JAMA Dermatology . 2019;2019", "ArticleIdList": ["PMC6439931", "30698622"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "25"}, {"Year": "2021", "Month": "12", "Day": "24"}, {"Year": "2022", "Month": "1", "Day": "21"}, {"Year": "2022", "Month": "3", "Day": "3", "Hour": "5", "Minute": "35"}, {"Year": "2022", "Month": "3", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "4", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "21"}], "PublicationStatus": "epublish", "ArticleIdList": ["35237320", "PMC8885178", "10.1155/2022/3149293"]}}], "PubmedBookArticle": []}